Jim Simons Immunic, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immunic, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 389,081 shares of IMUX stock, worth $389,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares

389,081

Previous 291,087 33.66%

Holding current value

$389,081

Previous $323,000 98.45%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.08 - $1.95 $105,833 - $191,088	97,994 Added 33.66%	389,081 $641,000
Q2 2024 Aug 09, 2024	SELL	$0.98 - $1.44 $447,060 - $656,904	-456,184 Reduced 61.05%	291,087 $323,000
Q1 2024 May 13, 2024	BUY	$1.14 - $1.53 $766,610 - $1.03 Million	672,465 Added 898.95%	747,271 $986,000
Q4 2023 Feb 13, 2024	SELL	$0.97 - $1.6 $487,516 - $804,150	-502,594 Reduced 87.04%	74,806 $112,000
Q3 2023 Nov 14, 2023	BUY	$1.35 - $2.87 $570,375 - $1.21 Million	422,500 Added 272.76%	577,400 $849,000
Q2 2023 Aug 11, 2023	SELL	$1.33 - $2.51 $296,004 - $558,625	-222,560 Reduced 58.96%	154,900 $389,000
Q1 2023 May 12, 2023	BUY	$1.35 - $2.87 $509,571 - $1.08 Million	377,460 New	377,460 $562,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $304,395 - $557,042	101,465 Added 347.48%	130,665 $413,000
Q2 2022 Aug 12, 2022	BUY	$3.13 - $12.25 $91,396 - $357,700	29,200 New	29,200 $101,000
Q4 2021 Feb 11, 2022	SELL	$7.34 - $10.25 $122,578 - $171,175	-16,700 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $134,435 - $221,943	16,700 New	16,700 $148,000
Q1 2021 May 13, 2021	SELL	$14.21 - $25.3 $190,414 - $339,020	-13,400 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$14.8 - $20.37 $325,600 - $448,140	-22,000 Reduced 62.15%	13,400 $205,000
Q3 2020 Nov 13, 2020	SELL	$11.74 - $22.0 $1.46 Million - $2.74 Million	-124,531 Reduced 77.87%	35,400 $657,000
Q2 2020 Aug 13, 2020	BUY	$5.67 - $15.86 $521,640 - $1.46 Million	92,000 Added 135.43%	159,931 $1.94 Million
Q1 2020 May 14, 2020	BUY	$4.22 - $9.8 $30,806 - $71,540	7,300 Added 12.04%	67,931 $411,000
Q4 2019 Feb 13, 2020	BUY	$6.4 - $10.23 $119,052 - $190,298	18,602 Added 44.26%	60,631 $588,000
Q3 2019 Nov 13, 2019	BUY	$10.0 - $17.01 $283,000 - $481,383	28,300 Added 206.13%	42,029 $420,000
Q2 2019 Aug 12, 2019	BUY	$7.88 - $33.2 $108,184 - $455,802	13,729 New	13,729 $157,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

56.2M

Call Options Held

100

Put Options Held

350K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account